Diffusion Pharmaceuticals Shares Owned By Institutions vs. Cash Per Share

DFFNDelisted Stock  USD 3.27  0.17  5.48%   
Based on Diffusion Pharmaceuticals' profitability indicators, Diffusion Pharmaceuticals may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Diffusion Pharmaceuticals' ability to earn profits and add value for shareholders.
For Diffusion Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Diffusion Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Diffusion Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Diffusion Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Diffusion Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Please note, there is a significant difference between Diffusion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Diffusion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Diffusion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Diffusion Pharmaceuticals Cash Per Share vs. Shares Owned By Institutions Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Diffusion Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Diffusion Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Diffusion Pharmaceuticals is rated below average in shares owned by institutions category among its peers. It is one of the top stocks in cash per share category among its peers fabricating about  1.23  of Cash Per Share per Shares Owned By Institutions. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diffusion Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Diffusion Cash Per Share vs. Shares Owned By Institutions

Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Diffusion Pharmaceuticals

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

 = 
10.27 %
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Diffusion Pharmaceuticals

Cash Per Share

 = 

Total Cash

Average Shares

 = 
12.68 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Diffusion Cash Per Share Comparison

Diffusion Pharmaceuticals is currently under evaluation in cash per share category among its peers.

Diffusion Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Diffusion Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Diffusion Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Diffusion Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Diffusion Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the bodys ability to deliver oxygen. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. Diffusion Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.

Diffusion Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Diffusion Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Diffusion Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Diffusion Pharmaceuticals' important profitability drivers and their relationship over time.

Use Diffusion Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Diffusion Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Diffusion Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Diffusion Pharmaceuticals Pair Trading

Diffusion Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to Diffusion Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Diffusion Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Diffusion Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Diffusion Pharmaceuticals to buy it.
The correlation of Diffusion Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Diffusion Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Diffusion Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Diffusion Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Diffusion Pharmaceuticals position

In addition to having Diffusion Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run IT Thematic Idea Now

IT
IT Theme
Information Technology (IT) companies and IT service providers across different domains. The IT theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize IT Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Consideration for investing in Diffusion Stock

If you are still planning to invest in Diffusion Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Diffusion Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine